Johnson & Johnson to Acquire V-Wave
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
Go back to Johnson & Johnson to Acquire V-Wave
August 20, 2024 8:40 AM EDT
(Updated - August 20, 2024 11:13 AM EDT)
Johnson & Johnson (NYSE: JNJ) announced Tuesday that it has struck an agreement to acquire V-Wave Ltd., a privately-held company specializing in treatments for heart failure.
The deal will see Johnson & Johnson make an upfront payment of $600 million, with the potential for an additional $1.1 billion in milestone payments.
V-Wave will join Johnson &... More
August 20, 2024 7:49 AM EDT
Johnson & Johnson (NYSE: JNJ) announced Tuesday that it has received U.S. Food and Drug Administration (FDA) approval for a combination treatment of RYBREVANT and LAZCLUZE for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) with specific EGFR mutations.
According to the company, it... More
